Dunn-Pirio, Anastasie M.
Heyman, Benjamin M.
Kaufman, Dan S.
Kinkel, Revere P.
Article History
First Online: 17 October 2019
Compliance with Ethical Standards
:
: Dan S. Kaufman reports grants and personal fees from Fate Therapeutics, for work unrelated to the topic of this manuscript. Revere P. Kinkel reports honararia for scientific consultation and/or educational programs sponsored by the company from Biogen, Genzyme/Sanofi and Genetech/Roche outside the submitted work.Anastasie M. Dunn-Pirio and Benjamin M. Heyman each declare no potential conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.